Biomedical researchers in academia and industry have the common goal of improving human health through science. The objective of this panel is to challenge the entrenched paradigms of both research environments, and engage local research communities in a discussion about how the different approaches to R&D contribute to the health of society. The discussion will hopefully evolve to include a variety of perspectives in this area. By examining differences that emerge, we hope to explore the interrelation between academia and industry, and how the diversity of science and opinions enrich the research areas related to medicine and healthcare. In addition, we hope to start discussions about potential collaborations between academia and industry during the event.
The panel members will be Susan Windham-Bannister (Biomedical Innovation Advisors & former Mass. Life Sciences Center CEO), Kenneth Kaitin (Professor and Director, Tufts Center for the Study of Drug Development, Tufts University School of Medicine, Tufts University), Harvey Lodish (Professor of Biology; Member, Whitehead Institute; Professor of Bioengineering), and Derek Lowe (Research Fellow at Vertex Pharmaceuticals & blogger of “In The Pipeline”). The panel discussion will take place on December 16th at 3pm at 250 Mass. Ave. in the Novartis auditorium with a reception to follow at 4:15pm. This event is open to the public and free; registration is required.